Olaparib and Radiotherapy in Inoperable Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Olaparib
Related studies linked through entity extraction aliases.
mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1
SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients
- Status
- COMPLETED
- Phase
- PHASE2
To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.
- Status
- COMPLETED
- Phase
- PHASE3
Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma
- Status
- COMPLETED
- Phase
- PHASE1
D081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Parp Inhibitor in Advanced Non-Small Cell Lung Cancer (PIN)
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking History
- Status
- COMPLETED
- Phase
- PHASE1
TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Olaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE1